ANTIPHOSPHOLIPID ANTIBODY SEROPREVALENCE AND ITS ASSOCIATION WITH PREGNANCY LOSS AMONG WOMEN IN SANA'A CITY, YEMEN: A PROSPECTIVE CASE-CONTROL STUDY
Genetics and Molecular Research · 01.06.2026
DOI: 10.4238/ezyjt488 ↗Kurz gefasst
Fall-Kontroll-Studie in der Zeitschrift Genetics and Molecular Research, online erschienen am 01.06.2026. Verfasst von Amal Ba-nafa und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).
Abstract (Originalsprache)
Background
Antiphospholipid syndrome (APS) is a leading cause of recurrent pregnancy loss in women of reproductive age. Data from conflict-affected low-resource settings such as Yemen remain scarce.
Objectives
To determine the seroprevalence of antiphospholipid antibodies (aPL-IgG) in women with and without pregnancy loss in Sana'a City, Yemen, and to evaluate associated clinical and epidemiological factors.
Methods
A prospective case-control study was conducted between January and May 2022 at three public and private hospitals in Sana'a. A total of 101 pregnant women were enrolled: 62 cases (women with pregnancy loss) and 39 controls (women without pregnancy loss). Serum antiphospholipid antibodies (IgG and IgM) against cardiolipin, phosphatidylserine, phosphatidylinositol, phosphatidic acid, and beta-2-glycoprotein I were detected by a validated ELISA kit with a cut-off of ≥10 GPL-U/ml for IgG positivity. Results: aPL-IgG positivity was detected in 19.4% of cases and 0% of controls (corrected OR = 19.6; 95% CI: 1.1–348.0; p = 0.003). All 12 seropositive participants were in the first trimester. Cases were significantly older (29.8 ± 5.9 vs. 25.8 ± 5.7 years; p = 0.001) and had significantly earlier gestational age at presentation. Among aPL-positive cases, 91.7% used aspirin and 33.3% used heparin. Assay validation demonstrated high analytical performance: sensitivity 91.8%, specificity 97.3%, and coefficient of variation
Zitieren
APA
Ba-nafa, A., Ahmed, R., Al-Awar, M. S., & Alyafrosi, O. A. (2026). ANTIPHOSPHOLIPID ANTIBODY SEROPREVALENCE AND ITS ASSOCIATION WITH PREGNANCY LOSS AMONG WOMEN IN SANA'A CITY, YEMEN: A PROSPECTIVE CASE-CONTROL STUDY. Genetics and Molecular Research. https://doi.org/10.4238/ezyjt488
Vancouver
Ba-nafa A, Ahmed R, Al-Awar MS, Alyafrosi OA. ANTIPHOSPHOLIPID ANTIBODY SEROPREVALENCE AND ITS ASSOCIATION WITH PREGNANCY LOSS AMONG WOMEN IN SANA'A CITY, YEMEN: A PROSPECTIVE CASE-CONTROL STUDY. Genetics and Molecular Research. 2026. doi:10.4238/ezyjt488
BibTeX
@article{Banafa2026,
author = {Ba-nafa, Amal and Ahmed, Radfan and Al-Awar, Mohammed S. and Alyafrosi, Ohood Ali},
title = {ANTIPHOSPHOLIPID ANTIBODY SEROPREVALENCE AND ITS ASSOCIATION WITH PREGNANCY LOSS AMONG WOMEN IN SANA'A CITY, YEMEN: A PROSPECTIVE CASE-CONTROL STUDY},
journal = {Genetics and Molecular Research},
year = {2026},
doi = {10.4238/ezyjt488}
}
EUVIMED